Literature DB >> 4101408

Thyroid suppressibility: follow-up for two years after antithyroid treatment.

R C Lowry, D Lowe, D R Hadden, D A Montgomery, J A Weaver.   

Abstract

In hyperthyroidism suppression and non-suppression of early radioiodine neck uptake by exogenous thyroid hormone after a course of antithyroid drugs does not indicate clearly those patients who will eventually relapse or have a remission. Sixty-four hyperthyroid patients have been followed up for two years after an 18 to 24 months' course of carbimazole. Twenty-eight patients had suppressed at the end of the carbimazole course and 20 of these remained in remission for two years, and 36 were non-suppressed and 21 of these relapsed.Patients with the highest neck uptakes relapsed soonest after stopping treatment. Pronounced rebound occurred in neck uptakes at one month after stopping treatment, both in patients who relapsed and in those who remained in remission. By one year after stopping treatment those who remained in remission had shown a further fall in early neck uptake. In two patients who relapsed after exposure to stressful events no change in 20-minute radioiodine neck uptakes was found in relation to the supposed stress.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4101408      PMCID: PMC1795896          DOI: 10.1136/bmj.2.5752.19

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  12 in total

1.  Thyroid-suppression test in the prognosis of hyperthyroidism treated by antithyroid drugs.

Authors:  C E CASSIDY; W P VANDERLAAN
Journal:  N Engl J Med       Date:  1960-06-16       Impact factor: 91.245

2.  Graves' disease: hyperthyroidism or hyperpituitarism.

Authors:  S C WERNER; H HAMILTON; M NEMETH
Journal:  J Clin Endocrinol Metab       Date:  1952-12       Impact factor: 5.958

3.  The effect of exogenous thyroxine on radioiodine uptake in normal subjects and in cases of thyrotoxicosis in remission.

Authors:  M E MORGANS; A K OLDHAM; W R TROTTER
Journal:  J Endocrinol       Date:  1952-07       Impact factor: 4.286

4.  Quantitative studies of iodine metabolism after long-term treatment of thyrotoxicosis with antithyroid drugs.

Authors:  R M Harden; W D Alexander; D A Koutras; M T Harrison; E Wayne
Journal:  J Clin Endocrinol Metab       Date:  1966-04       Impact factor: 5.958

5.  Development of thyroidal suppression by triiodothyronine during six months' treatment of thyrotoxicosis with antithyroid drugs.

Authors:  W D Alexander; R M Harden; J Shimmins; D McLarty; P McGill
Journal:  J Clin Endocrinol Metab       Date:  1967-12       Impact factor: 5.958

6.  Comparison of the early thyroidal iodide clearance with estimates obtained at later intervals.

Authors:  D A Koutras; J Sfontouris
Journal:  J Endocrinol       Date:  1966-06       Impact factor: 4.286

7.  Thyroidal suppression by triiodothyronine as a guide to duration of treatment of thyrotoxicosis with antithyroid drugs.

Authors:  W D Alexander; R M Harden; J Shimmins
Journal:  Lancet       Date:  1966-11-12       Impact factor: 79.321

8.  Emotion and non-specific infection as possible aetiological factors in Graves' disease. Their relation to thyroid suppressibility.

Authors:  W D Alexander; R M Harden; J Shimmins
Journal:  Lancet       Date:  1968-07-27       Impact factor: 79.321

9.  Thyroidal suppressibility after stopping long-term treatment of thyrotoxicosis with anti-thyroid drugs.

Authors:  W D Alexander; R M Harden; D McLarty; J Shimmins
Journal:  Metabolism       Date:  1969-01       Impact factor: 8.694

10.  Dissociation of serum LATS content and thyroid suppressibility during treatment of hyperthyroidism.

Authors:  I J Chopra; D H Solomon; D E Johnson; U Chopra; D A Fischer
Journal:  J Clin Endocrinol Metab       Date:  1970-04       Impact factor: 5.958

View more
  6 in total

1.  Tests of thyroid function in vivo.

Authors:  A W Goolden
Journal:  J Clin Pathol       Date:  1975-03       Impact factor: 3.411

2.  Response to TRH, serum thyroid hormone concentration, and serum markers of autoimmunity after antithyroid therapy in Graves' disease.

Authors:  B A Lamberg; A Aro; P Saarinen; T Tötterman; T Mäkinen
Journal:  J Endocrinol Invest       Date:  1978-01       Impact factor: 4.256

3.  Use of 99 Tc m for the routine assessment of thyroid function.

Authors:  A W Goolden; H I Glass; E D Williams
Journal:  Br Med J       Date:  1971-11-13

4.  Prevention and management of hypothyroidism after thyroidectomy for thyrotoxicosis.

Authors:  W Michie; J S Beck; J E Pollet
Journal:  World J Surg       Date:  1978-05       Impact factor: 3.352

5.  Are antithyroid drugs immunosuppressive?

Authors:  P Kendall-Taylor
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-18

6.  Chronic recurrent stress due to panic disorder does not precipitate Graves' disease.

Authors:  L Chiovato; M Marinò; G Perugi; E Fiore; L Montanelli; P Lapi; R Cavaliere; M Ciampi; A Patronelli; G Placidi; G F Placidi; G B Cassano; A Pinchera
Journal:  J Endocrinol Invest       Date:  1998-12       Impact factor: 4.256

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.